Total global 2013 sales totaled $28.5 million, up from 2012’s $27.4 million. Fourth quarter device sales, which totaled $7.3 million, dropped 1 percent compared to the same period last year.
Year-end orthopedic device sales reached $9.5 million, up nearly 22 percent from 2012’s $7.7 million in sales.
The company’s net income for 2013 was $13.8 billion, up from $10.5 billion in 2012.
More Articles on Devices:
Titan Spine Gains 5 Patents for Endoskeleton Interbody Devices
Budgetary Fund Could Pay to Eliminate Medical Device Tax
Intellirod Spine Secures $1.6M Loan From Ohio Third Frontier
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
